Interestingly, thyroid cancer alone was found to have a similar statistical significance for the ‘KRAS Signaling Down’ pathway (P < .0001, FDR < 0.0001) in the PSG+ versus PSG− groups. The gene discussed is KRAS; the disease is thyroid gland carcinoma.